ASO Visual Abstract: Impact of Mainstream Germline Genetic Testing with Expanded Eligibility for Early Stage Breast Cancer Patients in a Large Integrated Health System.

Autor: Shim V; Department of Surgery, Oakland, CA, USA. veronica.shim@kp.org., Karlea A; Department of Genetics, Oakland, CA, USA., Brenman LM; Department of Genetics, Oakland, CA, USA., Gul J; Division of Research, Oakland, CA, USA., Hoodfar E; Department of Genetics, Sacramento, CA, USA., Chan TD; Department of Surgery, Oakland, CA, USA., Engeman PC; Department of Surgery, South Sacramento, CA, USA., Sheldon VM; Department of Surgery, Central Valley, CA, USA., Thorne-Hadfield DM; Department of Radiology, San Rafael, CA, USA., Odele P; Department of Surgery, San Rafael, CA, USA., Vuong B; Department of Surgery, South Sacramento, CA, USA., McEvoy J; Department of Surgery, Central Valley, CA, USA., Chang CK; Department of Surgery, Oakland, CA, USA., Kotak D; Department of Medical Oncology, San Rafael, CA, USA., Habel LA; Division of Research, Oakland, CA, USA.
Jazyk: angličtina
Zdroj: Annals of surgical oncology [Ann Surg Oncol] 2024 Dec 04. Date of Electronic Publication: 2024 Dec 04.
DOI: 10.1245/s10434-024-16559-0
Abstrakt: Competing Interests: Disclosures: None
Databáze: MEDLINE